Autolus Therapeutics Ltd reported $10.52M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
AstraZeneca USD 303M 38M Jun/2025
Autolus Therapeutics Ltd USD 10.52M 17.35M Sep/2025
Hikma Pharmaceutical USD 20M 2M Jun/2025
Novartis USD 281M 8M Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025